PGEN - PRECIGEN, INC.

QQQ $ 473.06 $ -2.91 (-0.61 %)

DIA $ 417.40 $ -0.58 (-0.14 %)

SPY $ 562.82 $ -2.31 (-0.41 %)

TLT $ 100.89 $ -0.50 (-0.49 %)

GLD $ 237.56 $ -0.42 (-0.18 %)

Previous Close

$ 0.9998

Open

$ 0.99

Bid

$ 1.01 x 270

Ask

$ 1.02 x 800

Day's Range

$ 0.98 - $ 1.02

52 Week Range

$ 0.84 - $ 1.93

Volume

508,982

Average Volume

Market Cap

252.71M

Beta (5Y Monthly)

$ 0.99

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-19-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	03-06-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	03-01-2022	12-31-2021	10-K
12	11-08-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-10-2021	03-31-2021	10-Q
15	03-01-2021	12-31-2020	10-K
16	11-09-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	03-02-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-09-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	03-01-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-13-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-01-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-09-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-01-2017	12-31-2016	10-K
32	11-09-2016	09-30-2016	10-Q
33	08-09-2016	06-30-2016	10-Q
34	05-10-2016	03-31-2016	10-Q
35	02-29-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-10-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	03-02-2015	12-31-2014	10-K
40	11-13-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Assessing Precigen: Insights From 5 Financ...
08/15/2024 19:01:48

JMP Securities Maintains Market Outperform...
08/15/2024 15:37:02

JMP Securities analyst Jason Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and lowers the price target fr...

titan-machinery-reports-weak-preliminary-results-joins-precigen-gogoro-and-other-big-stocks-moving-lower-in-thursday-pre-market-session

Titan Machinery Reports Weak Preliminary R...
08/15/2024 12:11:53

HC Wainwright & Co. Maintains Buy on Preci...
08/15/2024 12:00:09

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and lowers the price targ...

why-lumentum-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket

Why Lumentum Shares Are Trading Higher By ...
08/15/2024 10:32:30

Precigen Q2 2024 GAAP EPS $(0.23) Misses $...
08/14/2024 20:10:42

Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.10) by...

more-than-20m-bet-on-precigen-check-out-these-3-stocks-under-5-insiders-are-aggressively-buying

More Than $20M Bet On Precigen? Check Out ...
08/14/2024 12:57:03

Precigen shares are trading lower after th...
08/08/2024 11:48:21

why-digital-turbine-shares-are-trading-higher-by-over-20-here-are-20-stocks-moving-premarket

Why Digital Turbine Shares Are Trading Hig...
08/08/2024 10:02:17

Reported Earlier, Precigen Prices $30M Pub...
08/08/2024 05:43:18

Precigen intends to use the net proceeds from the offering for advancing PRGN-2012 to regulatory approval and commercial readin...

Precigen Strategically Prioritizes Portfol...
08/06/2024 20:27:23

– PRGN-2012 is on track for a rolling BLA submission under an accelerated approval pathway; patient enrollment initiated in the...

Precigen Proposes $30M Public Offering Of ...
08/06/2024 20:26:33

Precigen, Inc. (NASDAQ:PGEN) today announced it has commenced a $30.0 million underwritten public offering of its common stock....

Precigen To Spearhead First Potential Gene...
07/23/2024 12:18:14

– Company strengthens focus on building and optimizing commercial readiness and pre-launchactivities for PRGN-2012 in recurren...

JMP Securities Reiterates Market Outperfor...
06/04/2024 12:32:39

JMP Securities analyst Jason Butler reiterates Precigen (NASDAQ:PGEN) with a Market Outperform and maintains $14 price target.

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Science Applications International Sha...
06/03/2024 17:56:53

6 Analysts Assess Precigen: What You Need ...
06/03/2024 17:00:15

HC Wainwright & Co. Reiterates Buy on Prec...
06/03/2024 16:21:09

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Precigen (NASDAQ:PGEN) with a Buy and maintains $6 price t...

Stifel Maintains Buy on Precigen, Raises P...
06/03/2024 16:20:22

Stifel analyst Benjamin Burnett maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $7 to $10.

Watching Precigen; Shares Spiking Higher A...
06/03/2024 14:27:20

Precigen Announces Study Data For PRGN-201...
06/03/2024 13:31:38

– Phase 1/2 pivotal study met the primary safety and efficacy endpoints –– 51% (18 out of 35) of patients achieved Complete...